Clinical Trials for Biochemical Recurrence of Malignant Neoplasm of Prostate

Find clinical trials for biochemical recurrence of malignant neoplasm of prostate. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

PROCARE - PROstate Cancer Real World Evidence Registry

NCT ID: NCT06835218

The PROCARE study is a clinical trial aimed at understanding the treatment and progression of prostate cancer in patients with different stages of the disease. Specifically, it focuses on men who h...

Recruiting

Type: observational Locations: Hamburg, , Germany, Ulm, , Germany +39 more

A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PET

NCT ID: NCT06859203

The REFINE study is investigating whether a special type of imaging called fluciclovine PET/CT can help find recurring prostate cancer in men who previously had inconclusive or negative results fro...

Recruiting

Type: observational Locations: Augsburg, Bavaria, Germany, Munich, Bavaria, Germany

Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer

NCT ID: NCT06657131

This clinical trial is studying a new diagnostic tool called [18F]PSMA-1007, which helps doctors detect prostate cancer that may have come back after initial treatment. The trial aims to see how we...

Recruiting

Type: observational Locations: Düsseldorf, Nrw, Germany

68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

NCT ID: NCT05847348

This clinical trial is studying a new imaging test called 68Ga-PSMA-11 to see how well it can detect prostate cancer that has returned after treatment in Chinese men. The trial includes patients wh...

Recruiting

Phase: PHASE3 Type: interventional Locations: Beijing, , China, Shanghai, , China +6 more

SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy

NCT ID: NCT04931979

This clinical trial is studying a combination treatment of pembrolizumab, an immunotherapy drug, and standard salvage radiation therapy (SRT) for men with recurrent prostate cancer after having the...

Recruiting

Phase: PHASE2 Type: interventional Locations: Freiburg, Baden Württemberg, Germany, Freiburg, , Germany

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions